{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T13:24:36Z","timestamp":1792243476408,"version":"4.4.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ygyno.2022.12.012","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T16:06:27Z","timestamp":1675094787000},"page":"234-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Beyond BRCA: Patterns of risk-reducing surgery for non-BRCA, homologous recombination repair pathway gene variant carriers"],"prefix":"10.1016","volume":"170","author":[{"given":"Sarah S.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah C.","family":"Karpel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheongeun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavana","family":"Pothuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2022.12.012_bb0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"issue":"21","key":"10.1016\/j.ygyno.2022.12.012_bb0010","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.2011.39.8545","article-title":"BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian ovarian Cancer study group","volume":"30","author":"Alsop","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.ygyno.2022.12.012_bb0015","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/cncr.21536","article-title":"BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases","volume":"104","author":"Pal","year":"2005","journal-title":"Cancer."},{"issue":"10","key":"10.1016\/j.ygyno.2022.12.012_bb0020","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/onc.2015.181","article-title":"Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations","volume":"35","author":"Golmard","year":"2016","journal-title":"Oncogene."},{"issue":"1","key":"10.1016\/j.ygyno.2022.12.012_bb0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13053-021-00169-y","article-title":"BRCA1 and BRCA2 mutations in ovarian cancer patients from Belarus: update","volume":"19","author":"Savanevich","year":"2021","journal-title":"Hered Cancer Clin. Pract."},{"issue":"9","key":"10.1016\/j.ygyno.2022.12.012_bb0030","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA."},{"issue":"1","key":"10.1016\/j.ygyno.2022.12.012_bb0035","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ygyno.2020.07.008","article-title":"Incidence and mortality of ovarian cancer at the global, regional, and national levels, 1990-2017","volume":"159","author":"Zheng","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2022.12.012_bb0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2014.09.009","article-title":"Society of gynecologic oncology statement on risk assessment for inherited gynecologic cancer predispositions","volume":"136","author":"Lancaster","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2022.12.012_bb0045","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ygyno.2011.12.415","article-title":"Hereditary ovarian cancer: beyond the usual suspects","volume":"124","author":"Pennington","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"26","key":"10.1016\/j.ygyno.2022.12.012_bb0050","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1200\/JCO.2015.61.2408","article-title":"Contribution of germline mutations in the RAD51B, RAD51C, and RAD51D genes to ovarian Cancer in the population","volume":"33","author":"Song","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.ygyno.2022.12.012_bb0055","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv214","article-title":"Germline mutations in the BRIP1, BARD1, PALB2, and NBN Genes in women with ovarian cancer","volume":"107","author":"Ramus","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.ygyno.2022.12.012_bb0060","doi-asserted-by":"crossref","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","article-title":"Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Daly","year":"2021","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"3","key":"10.1016\/j.ygyno.2022.12.012_bb0065","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1200\/OP.21.00382","article-title":"Risk-reducing bilateral Salpingo-oophorectomy for ovarian Cancer: a review and clinical guide for hereditary predisposition genes","volume":"18","author":"Liu","year":"2022","journal-title":"JCO Oncol. Pract."},{"issue":"12","key":"10.1016\/j.ygyno.2022.12.012_bb0070","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jclinepi.2004.03.012","article-title":"New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality","volume":"57","author":"Sundararajan","year":"2004","journal-title":"J. Clin. Epidemiol."},{"issue":"6","key":"10.1016\/j.ygyno.2022.12.012_bb0075","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries","volume":"173","author":"Quan","year":"2011","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ygyno.2022.12.012_bb0080","series-title":"Genetic\/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology","author":"Daly","year":"2022"},{"issue":"7","key":"10.1016\/j.ygyno.2022.12.012_bb0085","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1200\/JCO.19.01907","article-title":"Cancer risks associated with germline PALB2 pathogenic variants: an international study of 524 families","volume":"38","author":"Yang","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2022.12.012_bb0090","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jamaoncol.2015.5495","article-title":"Inherited mutations in women with ovarian carcinoma","volume":"2","author":"Norquist","year":"2016","journal-title":"JAMA Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2022.12.012_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14071786","article-title":"Uptake rates of risk-reducing surgeries for women at increased risk of hereditary breast and ovarian Cancer applied to cost-effectiveness analyses: a scoping systematic review","volume":"14","author":"Simoes Correa Galendi","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.ygyno.2022.12.012_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2021.06.070","article-title":"Uptake and timing of risk-reducing salpingo-oophorectomy among patients with BRCA1 and BRCA2 mutations","volume":"225","author":"Smith","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ygyno.2022.12.012_bb0105","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/tbj.12521","article-title":"Surgical decision making in the BRCA-positive population: institutional experience and comparison with recent literature","volume":"22","author":"Flippo-Morton","year":"2016","journal-title":"Breast J."},{"issue":"2","key":"10.1016\/j.ygyno.2022.12.012_bb0110","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/jmedgenet-2020-107356","article-title":"Uptake and efficacy of bilateral risk reducing surgery in unaffected female BRCA1 and BRCA2 carriers","volume":"59","author":"Marcinkute","year":"2022","journal-title":"J. Med. Genet."},{"issue":"13","key":"10.1016\/j.ygyno.2022.12.012_bb0115","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1002\/cncr.30621","article-title":"Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors","volume":"123","author":"Cragun","year":"2017","journal-title":"Cancer."},{"key":"10.1016\/j.ygyno.2022.12.012_bb0120","first-page":"5","article-title":"Systemic barriers to risk-reducing interventions for hereditary Cancer syndromes: implications for health care inequities. JCO precis","author":"Mittendorf","year":"2021","journal-title":"Oncol."},{"issue":"22","key":"10.1016\/j.ygyno.2022.12.012_bb0125","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1002\/cncr.29612","article-title":"Impact of patient navigation in eliminating economic disparities in cancer care","volume":"121","author":"Rodday","year":"2015","journal-title":"Cancer."},{"issue":"1","key":"10.1016\/j.ygyno.2022.12.012_bb0130","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/GME.0000000000001422","article-title":"Exploring factors that impact uptake of risk-reducing bilateral salpingo-oophorectomy (RRBSO) in high-risk women","volume":"27","author":"Hickey","year":"2020","journal-title":"Menopause."},{"key":"10.1016\/j.ygyno.2022.12.012_bb0135","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1186\/s12885-015-1597-y","article-title":"Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1\/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study","volume":"15","author":"Harmsen","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ygyno.2022.12.012_bb0140","unstructured":"K.H. Lu, D.R. Nebgen, B. Norquist, D.J. Bowen, J.N. Bakkum-Gamez, I. Romero, K. Long Roche, D.A. Levine, B. Soletsky, J. Carter, M. Hickey, J. Crase, K. Gavin, D. Polinsky, E.M. Swisher, WISP: A prospective, multi-center trial of salpingectomy with delayed oophorectomy versus risk reducing salpingo-oophorectomy in women at increased risk for hereditary cancer, Society of Gynecologic Oncology Annual Meeting; 2019 March, 2019 Honolulu, HI."},{"key":"10.1016\/j.ygyno.2022.12.012_bb0145","series-title":"Society of Gynecologic Oncology Annual Meeting; 2019 March","article-title":"Worry and regret in the prospective multicentre TUBA study in BRCA 1\/2 mutation carriers","author":"Steenbeek MPH","year":"2019"},{"issue":"3","key":"10.1016\/j.ygyno.2022.12.012_bb0150","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/AOG.0000000000003421","article-title":"Health care provider adherence to surgical guidelines for risk-reducing Salpingo-oophorectomy","volume":"134","author":"Wilhite","year":"2019","journal-title":"Obstet. Gynecol."},{"issue":"10","key":"10.1016\/j.ygyno.2022.12.012_bb0155","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/ijgc-2020-001536","article-title":"Management of high, moderate, and low penetrance ovarian cancer susceptibility mutations: an assessment of current risk reduction practices","volume":"30","author":"Watson","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2022.12.012_bb0160","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/AOG.0000000000004643","article-title":"Insurance-mediated disparities in gynecologic oncology care","volume":"139","author":"Bodurtha Smith","year":"2022","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2022.12.012_bb0165","series-title":"Society of Gynecologic Oncology Annual Meeting","article-title":"Referral patterns for gynecologic oncology consultation","author":"Shalowitz","year":"2021"},{"key":"10.1016\/j.ygyno.2022.12.012_bib166","author":"Gupta"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825822020121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825822020121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:49:33Z","timestamp":1715820573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825822020121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":34,"alternative-id":["S0090825822020121"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2022.12.012","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond BRCA: Patterns of risk-reducing surgery for non-BRCA, homologous recombination repair pathway gene variant carriers","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2022.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}